I'd argue it's marginal. For some sort of scientific benefit, at least, new knowledge (e.g. what to do or what not to do) is needed.
* For the experts involved, the approach, while novel in historical terms, was application of known techniques. Further, to prove the treatment, they'd have needed a positive outcome, which sadly wasn't the case. So, some technical benefit here, but hindered by the negative outcome (and the possible retraction of the paper).
* They haven't really learned much more about what not to do, as some of the major criticisms of the study were that because of the approach taken and (arguably) the corners cut, it was predictably dangerous. Again, all of this was known - it was the failure to apply established principles that was the problem.
* It appears that (apart from this article) no details of the exact case have been released. A thorough write-up of the science and the clinical study would possibly add some benefit to science, but that's not been done.
Also, I am pretty sure this wouldn't have been allowed in the EU and the US, at least not with that few studies on animals. And with good reasons.
Also, you forget that the company probably also payed a lot for this, so it isn't like the total costs is limited to what was illegally paid to the researchers.
I'm in two minds about this.
On the one hand, at face value the funding and payments seem dubious - especially with the mention of one of the doctors returning his payments, suggesting they were for his personal enrichment, rather than payment for the costs of the treatment development and trial.
On the other hand, the parents were literally funding the creation, for the first time ever, of a highly complex treatment essentially custom-made for their daughter's condition. This required a lot of detailed and expensive science, with the generation of a mouse model of the disease, followed by development of the treatment, and then the testing of this in monkeys. In US/EU, this work would likely cost millions of dollars/euros, and it's not unreasonable that it would also cost a significant sum of money in China.